TotalMarketCap

Travere Therapeutics

TVTXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$4.704 B

$49.00 -6.52%

Close of 6 Nov 2026

As of 6 Nov 2026, Travere Therapeutics (TVTX) has a market capitalization of $4.70B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$490.7M

#1902 by revenue

Earnings

-$25.5M

Loss-making

Shares outstanding

95,992,155

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #53VeradermicsMANE$5.38B
  2. #54Cogent BiosciencesCOGT$5.14B
  3. #55Travere TherapeuticsTVTX$4.70B
  4. #56Dianthus TherapeuticsDNTH$4.69B
  5. #57ErascaERAS$4.64B

What if Travere Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$294,158.14

Per share 6,003× higher

Bitcoin $1.53T

$15,916.38

Per share 325× higher

Apple $5.02T

$52,252.01

Per share 1,066× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Travere Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.